Zydus | Business Upturn

Latest Articles

Zydus and Lupin shares in focus today after Astellas raises Mirabegron guidance by 80%

Stock Market · Oct 31, 2025

blank

Top stocks to watch today, October 7: Reliance Industries, Bharti Airtel, LTIMindtree, Zydus, Brigade Enterprises and more

Stock Market · Oct 7, 2025

Stock Market

Top stocks to watch on August 11: Tata Motors, Dr. Reddy’s Laboratories, IDFC First Bank, Zydus and more

Stock Market · Aug 11, 2025

blank

Top Stocks in focus on June 19: Hero MotoCorp, Jio Financial, Vodafone Idea, Tata Elxsi, Zydus and more

Stock Market · Jun 19, 2025

blank

Zydus completes USFDA inspection at oncology plant with two minor observations, none related to data integrity

Corporates · Jun 18, 2025

By Aditya Bhagchandani

blank

Zydus shares in focus after US Court rejects plea in Astellas Patent case

Stock Market · Jun 13, 2025

blank

Zydus receives EIR with VAI classification from USFDA for Dabhasa API facility

Corporates · Jun 10, 2025

blank

Top stocks to watch today, June 4: HDFC Bank, Wipro, Ashok Leyland, Zydus, Yes Bank and more

Corporates · Jun 4, 2025

blank

Zydus secures licensing rights for next-gen immuno-oncology platforms from US-based Agenus

Corporates · Jun 3, 2025

blank

Zydus receives tentative USFDA approval for Rifaximin Tablets, 550 mg

Corporates · Jun 2, 2025

blank

Zydus receives USFDA Fast Track Designation for Usnoflast in the treatment of ALS

Corporates · May 28, 2025

blank

Zydus receives EIR from USFDA for its Ambernath API manufacturing facility

Corporates · May 14, 2025

blank

Zydus gets USFDA final approval for Niacin Extended-Release Tablets

Corporates · Apr 30, 2025

blank

Zydus shares nearly jump 3% on USFDA approval for Apalutamide Tablets

Stock Market · Mar 19, 2025

blank

Zydus gets U.S. FDA nod for 60 mg Apalutamide Tablets

Corporates · Mar 18, 2025

Showing 15 of 34 articles